Advertisement
Screener

MUSTANG BIO, INC. (MBIO) Investing Cash Flow

2.8 / 5 stars · 68/120 Roast Me

MUSTANG BIO, INC. Investing Cash Flow

MUSTANG BIO, INC. (MBIO) reported Investing Cash Flow of $0 for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.

Financial Statements › Cash Flow › Investing Activities

us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2026-08-05

  • MUSTANG BIO, INC. net cash provided by (used in) investing activities for the quarter ending 2026-06-30 was $0.00.
  • MUSTANG BIO, INC. net cash provided by (used in) investing activities for the quarter ending 2026-03-31 was $0.00, a 100.00% decline year-over-year.
  • MUSTANG BIO, INC. net cash provided by (used in) investing activities for the quarter ending 2025-12-31 was $0.00.
  • MUSTANG BIO, INC. net cash provided by (used in) investing activities for the quarter ending 2025-09-30 was $0.00.
  • MUSTANG BIO, INC. net cash provided by (used in) investing activities for fiscal 2025 was $1.17M.
  • MUSTANG BIO, INC. net cash provided by (used in) investing activities for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
  • MUSTANG BIO, INC. net cash provided by (used in) investing activities for fiscal 2023 was $5.89M.
  • MUSTANG BIO, INC. net cash provided by (used in) investing activities for fiscal 2022 was -$2.95M.
Period endNet Cash Provided by (Used in) Investing Activities 3 monthNet Cash Provided by (Used in) Investing Activities 6 monthNet Cash Provided by (Used in) Investing Activities 9 monthNet Cash Provided by (Used in) Investing Activities 10 monthNet Cash Provided by (Used in) Investing Activities 12 month
2026-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05
$0.00
10-Q · filed 2026-08-05
$0.00
derived: sum of 3 quarters · filed 2026-08-05
$0.00
derived: sum of 4 quarters · filed 2026-08-05
2026-03-31$0.00
10-Q · filed 2026-05-05
$0.00
derived: sum of 2 quarters · filed 2026-05-05
$0.00
derived: sum of 3 quarters · filed 2026-05-05
$0.00
derived: sum of 4 quarters · filed 2026-08-05
2025-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19
$0.00
derived: sum of 2 quarters · filed 2026-03-19
$0.00
derived: sum of 3 quarters · filed 2026-08-05
$1.17M
10-K · filed 2026-03-19
2025-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07
$0.00
derived: sum of 2 quarters · filed 2026-08-05
$1.17M
10-Q · filed 2025-11-07
$1.17M
derived: sum of 4 quarters · filed 2026-08-05
2025-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05
$1.17M
10-Q · filed 2026-08-05
$1.17M
derived: sum of 3 quarters · filed 2026-08-05
$1.17M
derived: sum of 4 quarters · filed 2026-08-05
2025-03-31$1.17M
10-Q · filed 2026-05-05
$1.17M
derived: sum of 2 quarters · filed 2026-05-05
$1.17M
derived: sum of 3 quarters · filed 2026-05-05
$1.17M
derived: sum of 4 quarters · filed 2026-05-05
2024-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19
$0.00
derived: sum of 2 quarters · filed 2026-03-19
$0.00
derived: sum of 3 quarters · filed 2026-03-19
$0.00
10-K · filed 2026-03-19
2024-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07
$0.00
derived: sum of 2 quarters · filed 2025-11-07
$0.00
10-Q · filed 2025-11-07
-$30.00K
derived: sum of 4 quarters · filed 2025-11-07
2024-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08
$0.00
10-Q · filed 2025-08-08
-$30.00K
derived: sum of 3 quarters · filed 2025-08-08
$5.92M
derived: sum of 4 quarters · filed 2025-08-08
2024-03-31$0.00
10-Q · filed 2025-05-14
-$30.00K
derived: sum of 2 quarters · filed 2025-05-14
$5.92M
derived: sum of 3 quarters · filed 2025-05-14
$5.89M
derived: sum of 4 quarters · filed 2025-05-14
2023-12-31-$30.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28
$5.92M
derived: sum of 2 quarters · filed 2025-03-28
$5.89M
derived: sum of 3 quarters · filed 2025-03-28
$5.89M
10-K · filed 2025-03-28
2023-09-30$5.95M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08
$5.92M
derived: sum of 2 quarters · filed 2024-11-08
$5.92M
10-Q · filed 2024-11-08
$5.50M
derived: sum of 4 quarters · filed 2024-11-08
2023-06-30-$34.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13
-$34.00K
10-Q · filed 2024-08-13
-$454.00K
derived: sum of 3 quarters · filed 2024-08-13
-$1.35M
derived: sum of 4 quarters · filed 2024-08-13
2023-03-31$0.00
10-Q · filed 2024-05-15
-$420.00K
derived: sum of 2 quarters · filed 2024-05-15
-$1.31M
derived: sum of 3 quarters · filed 2024-05-15
-$1.62M
derived: sum of 4 quarters · filed 2024-05-15
2022-12-31-$420.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-11
-$1.31M
derived: sum of 2 quarters · filed 2024-03-11
-$1.62M
derived: sum of 3 quarters · filed 2024-03-11
-$2.95M
10-K · filed 2024-03-11
2022-09-30-$892.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14
-$1.20M
derived: sum of 2 quarters · filed 2023-11-14
-$2.53M
10-Q · filed 2023-11-14
-$4.01M
derived: sum of 4 quarters · filed 2023-11-14
2022-06-30-$306.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14
-$1.64M
10-Q · filed 2023-08-14
-$3.12M
derived: sum of 3 quarters · filed 2023-08-14
-$4.11M
derived: sum of 4 quarters · filed 2023-08-14
2022-03-31-$1.33M
10-Q · filed 2023-05-12
-$2.81M
derived: sum of 2 quarters · filed 2023-05-12
-$3.80M
derived: sum of 3 quarters · filed 2023-05-12
-$6.24M
derived: sum of 4 quarters · filed 2023-05-12
2021-12-31-$1.48M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30
-$2.47M
derived: sum of 2 quarters · filed 2023-03-30
-$4.91M
derived: sum of 3 quarters · filed 2023-03-30
-$5.37M
10-K · filed 2023-03-30
2021-09-30-$990.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14
-$3.43M
derived: sum of 2 quarters · filed 2022-11-14
-$3.89M
10-Q · filed 2022-11-14
-$5.35M
derived: sum of 4 quarters · filed 2022-11-14
2021-06-30-$2.44M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11
-$2.90M
10-Q · filed 2022-08-11
-$4.36M
derived: sum of 3 quarters · filed 2022-08-11
-$5.97M
derived: sum of 4 quarters · filed 2022-08-11
2021-03-31-$458.00K
10-Q · filed 2022-05-12
-$1.92M
derived: sum of 2 quarters · filed 2022-05-12
-$3.53M
derived: sum of 3 quarters · filed 2022-05-12
-$4.34M
derived: sum of 4 quarters · filed 2022-05-12
2020-12-31-$1.46M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-23
-$3.07M
derived: sum of 2 quarters · filed 2022-03-23
-$3.89M
derived: sum of 3 quarters · filed 2022-03-23
-$4.41M
10-K · filed 2022-03-23
2020-09-30-$1.61M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12
-$2.42M
derived: sum of 2 quarters · filed 2021-11-12
-$2.95M
10-Q · filed 2021-11-12
-$4.34M
derived: sum of 4 quarters · filed 2021-11-12
2020-06-30-$814.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16
-$1.34M
10-Q · filed 2021-08-16
-$2.73M
derived: sum of 3 quarters · filed 2021-08-16
-$3.63M
derived: sum of 4 quarters · filed 2021-08-16
2020-03-31-$526.00K
10-Q · filed 2021-05-14
-$1.92M
derived: sum of 2 quarters · filed 2021-05-14
-$2.82M
derived: sum of 3 quarters · filed 2021-05-14
$1.38M
derived: sum of 4 quarters · filed 2021-05-14
2019-12-31-$1.39M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-24
-$2.29M
derived: sum of 2 quarters · filed 2021-03-24
$1.91M
derived: sum of 3 quarters · filed 2021-03-24
$13.91M
10-K · filed 2021-03-24
2019-09-30-$899.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06
$3.30M
derived: sum of 2 quarters · filed 2020-11-06
$15.30M
10-Q · filed 2020-11-06
$20.00M
derived: sum of 4 quarters · filed 2020-11-06
2019-06-30$4.20M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10
$16.20M
10-Q · filed 2020-08-10
$20.89M
derived: sum of 3 quarters · filed 2020-08-10
$31.25M
derived: sum of 4 quarters · filed 2020-08-10
2019-03-31$12.00M
10-Q · filed 2020-05-11
$16.70M
derived: sum of 2 quarters · filed 2020-05-11
$27.05M
derived: sum of 3 quarters · filed 2020-05-11
$24.31M
derived: sum of 4 quarters · filed 2020-05-11
2018-12-31$4.70M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16
$15.05M
derived: sum of 2 quarters · filed 2020-03-16
$12.31M
derived: sum of 3 quarters · filed 2020-03-16
$557.00K
10-K · filed 2020-03-16
2018-09-30$10.35M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12
$7.61M
derived: sum of 2 quarters · filed 2019-11-12
-$4.14M
10-Q · filed 2019-11-12
$3.29M
derived: sum of 4 quarters · filed 2019-11-12
2018-06-30-$2.74M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09
-$14.49M
10-Q · filed 2019-08-09
-$7.06M
derived: sum of 3 quarters · filed 2019-08-09
-$22.93M
derived: sum of 4 quarters · filed 2019-08-09
2018-03-31-$11.75M
10-Q · filed 2019-05-10
-$4.32M
derived: sum of 2 quarters · filed 2019-05-10
-$20.19M
derived: sum of 3 quarters · filed 2019-05-10
-$40.43M
derived: sum of 4 quarters · filed 2019-05-10
2017-12-31$7.43M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18
-$8.44M
derived: sum of 2 quarters · filed 2019-03-18
-$28.68M
derived: sum of 3 quarters · filed 2019-03-18
-$29.05M
10-K · filed 2019-03-18
2017-09-30-$15.87M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13
-$36.11M
derived: sum of 2 quarters · filed 2018-11-13
-$36.48M
10-Q · filed 2018-11-13
-$36.48M
derived: sum of 4 quarters · filed 2018-11-13
2017-06-30-$20.24M
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-13
-$20.61M
10-Q · filed 2018-08-13
-$20.61M
derived: sum of 3 quarters · filed 2018-08-13
2017-03-31-$375.00K
10-Q · filed 2018-05-14
-$375.00K
derived: sum of 2 quarters · filed 2018-05-14
2016-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-29
$0.00
10-K · filed 2018-03-29
2016-09-30$0.00
10-Q · filed 2017-11-14
2015-12-31-$2.00M
10-K · filed 2018-03-29

Similar stocks

Stock NameCountryMarket CapPE Ratio
Vistagen Therapeutics, Inc. (VTGN)United States$0.013B-0.14
AEON Biopharma, Inc. (AEON)United States$0.013B-0.36
LISATA THERAPEUTICS, INC. (LSTA)United States$0.014B-2.13
Tempest Therapeutics, Inc. (TPST)United States$0.013B
Aspire Biopharma Holdings, Inc. (ASBP)United States$0.012B-0.60
BIOVIE INC. (BIVI)United States$0.012B
BullFrog AI Holdings, Inc. (BFRG)United States$0.014B
ADIAL PHARMACEUTICALS, INC. (ADIL)United States$0.012B
Vyome Holdings, Inc (HIND)United States$0.014B-1.38
Tvardi Therapeutics, Inc. (TVRD)United States$0.014B